Search Result "cataract treatment in canines"
Biomarkers of Oxidative Stress and Cataract. Novel Drug Delivery Therapeutic Strategies Targeting Telomere Reduction and the Expression of Telomerase Activity in the Lens Epithelial Cells with N-Acetylcarnosine Lubricant Eye Drops: Anti-Cataract which Helps to Prevent and Treat Cataracts in the Eyes of Dogs and other Animals
Journal: Current Drug Delivery
Volume: 11 Issue: 1 Year: 2014 Page: 24-61
Author(s): Mark A. Babizhayev,Yegor E. Yegorov
Canine Nutritional Model: Influence of Age, Diet, and Genetics on Health and Well-Being
Journal: Current Nutrition & Food Science
Volume: 2 Issue: 2 Year: 2006 Page: 115-126
Author(s): Kelly S. Swanson, Lawrence B. Schook
Revival of the Lens Transparency with N-Acetylcarnosine
Journal: Current Drug Therapy
Volume: 1 Issue: 1 Year: 2006 Page: 91-116
Author(s): Mark A. Babizhayev, Anatoly I. Deyev, Valentina N. Yermakova, Valerii V. Remenshchikov, Johan Bours
Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 10 Issue: 2 Year: 2016 Page: 82-129
Author(s): Mark A. Babizhayev,Yegor E. Yegorov
Peptide Drugs: Current Status and Treatment for the Treatment ofVarious Diseases
Journal: Current Drug Research Reviews
Volume: 16 Issue: 3 Year: 2024 Page: 381-394
Author(s):
Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine),Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl-L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 4 Issue: 3 Year: 2010 Page: 198-230
Author(s): Mark A. Babizhayev, Yegor E. Yegorov
New Genetic and Pharmacological Treatments for Cystic Fibrosis
Journal: Current Pediatric Reviews
Volume: 5 Issue: 1 Year: 2009 Page: 8-27
Author(s): Massimo Conese, Mario Romano, Maria Lucia Furnari, Elena Copreni, Ida De Fino, Francesca Pardo, Luis V. J. Galietta
Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 4763-4779
Author(s): Ryan J. Mailloux
Treatment for Radiation-Induced Pulmonary Late Effects: Spoiled for Choice or Looking in the Wrong Direction?
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 1386-1394
Author(s): Jacqueline P. Williams, Carl J. Johnston, Jacob N. Finkelstein
From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 7 Year: 2013 Page: 1069-1087
Author(s): Petr Babula, Michal Masarik, Vojtech Adam, Ivo Provaznik, Rene Kizek